Zobrazeno 1 - 10
of 207
pro vyhledávání: '"Miquel Navasa"'
Autor:
David Aguirre-Villarreal, Maximiliano Servin-Rojas, Aczel Sánchez-Cedillo, Mariana Chávez-Villa, Roberto Hernandez-Alejandro, Juan Pablo Arab, Isaac Ruiz, Karla P. Avendaño-Castro, Maria A. Matamoros, Enrique Adames-Almengor, Javier Diaz-Ferrer, Erika Faride Rodriguez-Aguilar, Victor Manuel Paez-Zayas, Alan G. Contreras, Mario R. Alvares-da-Silva, Manuel Mendizabal, Claudia P. Oliveira, Miquel Navasa, Ignacio García-Juárez
Publikováno v:
The Lancet Regional Health. Americas, Vol 28, Iss , Pp 100633- (2023)
Summary: Healthcare systems in Latin America are broadly heterogeneous, but all of them are burdened by a dramatic rise in liver disease. Some challenges that these countries face include an increase in patients requiring a transplant, insufficient r
Externí odkaz:
https://doaj.org/article/bb7acac37c2c4f81b0a883aba4be6722
Autor:
Jose Rios, Raquel Garcia, Jordi Colmenero, Eva López, Yolanda López-Púa, Miquel Navasa, Antoni Trilla, Anna Durà, Ana Guash
Publikováno v:
BMJ Open Quality, Vol 12, Iss 3 (2023)
Background The management of liver transplantation has become a complex process involving different healthcare professionals. Teamwork, standardisation and definition of the best practices are essential for success, patient satisfaction and society
Externí odkaz:
https://doaj.org/article/39420da5e6044e3cacdc8d23a0238b80
Autor:
Olga Millán, Pablo Ruiz, Judit Julian, Ana Lizana, Yiliam Fundora, Gonzalo Crespo, Jordi Colmenero, Miquel Navasa, Mercè Brunet
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe use of noninvasive biomarkers may avoid the need for liver biopsy (LB) and could guide immunosuppression adjustment in liver transplantation (LT). The aims of this study were: to confirm the predictive and diagnostic capacity of plasm
Externí odkaz:
https://doaj.org/article/af6700a1eae642808d0bd4199c0be5f0
Autor:
Juanita Pérez-Escobar, Jose Victor Jimenez, Erika Faride Rodríguez-Aguilar, Maximiliano Servín-Rojas, Jesus Ruiz-Manriquez, Luisa Safar-Boueri, Eduardo Carrillo-Maravilla, Miquel Navasa, Ignacio García-Juárez
Publikováno v:
Annals of Hepatology, Vol 28, Iss 1, Pp 100760- (2023)
The use of immunosuppressive medications for solid organ transplantation is associated with cardiovascular, metabolic, and oncologic complications. On the other hand, the development of graft rejection is associated with increased mortality and graft
Externí odkaz:
https://doaj.org/article/4def5aee75444e0e898bf109ac987084
Autor:
Lydia Sastre, MD, Raquel García, RN, Julián-Gonzalo Gándara, MD, Patricia Fernández-Llama, MD, Antonio J. Amor, MD, Cristina Sierra, MD, Laia Escudé, MD, Pablo Ruiz, MD, Jordi Colmenero, MD, Emilio Ortega, MD, Miquel Navasa, MD, Gonzalo Crespo, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 1, p e1272 (2022)
Background. Long-term cardiovascular (CV) events are a frequent cause of death and disability after liver transplant (LT). Although a more in-depth, risk-adapted control of CV risk factors may result in improved post-LT CV outcomes, an accurate strat
Externí odkaz:
https://doaj.org/article/07131f40889b488db0d7a9dd1996eb97
Autor:
Louis Shekhtman, Miquel Navasa, Natasha Sansone, Gonzalo Crespo, Gitanjali Subramanya, Tje Lin Chung, E Fabian Cardozo-Ojeda, Sofía Pérez-del-Pulgar, Alan S Perelson, Scott J Cotler, Xavier Forns, Susan L Uprichard, Harel Dahari
Publikováno v:
eLife, Vol 10 (2021)
While the liver, specifically hepatocytes, are widely accepted as the main source of hepatitis C virus (HCV) production, the role of the liver/hepatocytes in clearance of circulating HCV remains unknown. Frequent HCV kinetic data were recorded and ma
Externí odkaz:
https://doaj.org/article/88ec9d007d544a56ba1441581f7bf611
Autor:
Joan Roselló-Catafau, Arnau Panisello-Roselló, Gianfranco Pasut, Miquel Navasa, Jacques Pirenne, René Adam
Publikováno v:
Acta Cirúrgica Brasileira, Vol 35, Iss 1 (2020)
Abstract Solid organ transplantation is a very complex process, in which the storage of the graft in a preservation solution is mandatory in order to extend ischemic times and contain further damage. The condition in which the organ is transplanted i
Externí odkaz:
https://doaj.org/article/5dd5181b9aeb46a9833e176db7e9897e
Autor:
Xavier Forns, Didier Samuel, David Mutimer, Stefano Fagiuoli, Miquel Navasa, Kosh Agarwal, Marina Berenguer, Massimo Colombo, Kerstin Herzer, Frederik Nevens, Bjorn Daems, Katrien Janssen, Sivi Ouwerkerk-Mahadevan, Holly Kimko, Erkki Lathouwers, James Witek, Rodica Van Solingen-Ristea
Publikováno v:
Annals of Hepatology, Vol 15, Iss 4, Pp 512-523 (2016)
Background and rationale. The REPLACE study (NCT01571583) investigated telaprevir-based triple therapy in patients who have recurrent genotype 1 hepatitis C virus (HCV) infection following liver transplantation and are on a stable immunosuppressant r
Externí odkaz:
https://doaj.org/article/b851a19ac46e4b3cb62b33c6ad84da6e
Autor:
Ana Isabel López-Lazcano, Antoni Gual, Jordi Colmenero, Elsa Caballería, Anna Lligoña, Miquel Navasa, Gonzalo Crespo, Eva López, Hugo López-Pelayo
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 9, p 2710 (2020)
Tobacco use is more prevalent among alcohol liver disease (ALD) transplant patients and exerts harmful effects to the patient and to the graft. The aims of this study were to examine the impact of smoking status (nonsmoker, ex-smoker, active smoker)
Externí odkaz:
https://doaj.org/article/cd8a3736427444b188121fe8563470a4
Autor:
Nieves Embade, Zoe Mariño, Tammo Diercks, Ainara Cano, Sabela Lens, Diana Cabrera, Miquel Navasa, Juan M Falcón-Pérez, Joan Caballería, Azucena Castro, Jaume Bosch, José M Mato, Oscar Millet
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155094 (2016)
Several etiologies result in chronic liver diseases including chronic hepatitis C virus infection (HCV). Despite its high incidence and the severe economic and medical consequences, liver disease is still commonly overlooked due to the lack of effici
Externí odkaz:
https://doaj.org/article/b89e7eec31b24f828162a80474dda1dc